This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zheng, W. Articles by Hein, D. W. Search for Related Content PubMed PubMed Citation Articles by Zheng, W. Articles by Hein, D. W.

N-Acetyltransferase 1 Genetic Polymorphism, Cigarette Smoking, Well-Done Meat Intake, and Breast Cancer Risk¹

Division of Epidemiology, University of Minnesota School of Public Health, Minneapolis, Minnesota 55454 [W. Z., D. R. C., T. A. S., A. R. F.]; University of South Carolina School of Public Health and South Carolina Cancer Center, Columbia, South Carolina 29203 [W.Z., W-Q. W.]; Department of Pharmacology and Toxicology, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58202 [A. C. D., D. W. H.]; Department of Preventive Medicine and Environmental Health, University of Iowa College of Medicine, Iowa City, Iowa 52242 [J. R. C.]; and Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky 40292 [D. W. H.]

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
N-Acetyltransferase 1 (NAT1), encoded by the polymorphic NAT1 gene, has been shown to be one of the major enzymes in human breast tissue that activates aromatic and heterocyclic amines. Humans are mainly exposed to these carcinogens through cigarette smoking and consumption of well-done meat. To test the hypothesis that variations in the NAT1 gene are related to breast cancer risk, particularly among women who smoke or consume high levels of well-done meat, a nested case-control study was conducted in a prospective cohort study of 41,837 postmenopausal Iowa women. Information on cigarette smoking and other breast cancer risk factors was obtained at the baseline survey conducted in 1986. DNA samples and information on the consumption of well-done meat were obtained, in the case-control study, from breast cancer cases diagnosed from 1992 to 1994 and a random sample of cancer-free cohort members. Genomic DNA samples obtained from 154 cases and 330 controls were assayed for 11 NAT1 alleles (NAT1*3, *4, *5, *10, *11, *14, *15, *16, *17, *19, and *22). The NAT1*4 allele was the predominant allele observed in this study population, accounting for 73.2% (72.4% in cases versus 73.8% in controls) of the total alleles analyzed. Compared to controls, breast cancer cases had a slightly higher frequency of the NAT1*10 allele (18.8% in cases versus 17.3% in controls) and a substantially higher frequency of the NAT1*11 allele (3.6% versus 1.2%). In multivariate analyses, we found a 30% [95% confidence interval (CI) = 0.8–1.9] elevated risk of breast cancer associated with the NAT1*10 allele and a nearly 4-fold (95% CI = 1.5–10.5) elevated risk associated with the NAT1*11 allele. The positive association of breast cancer with the NAT1*11 allele was more evident among smokers [odds ratio (OR) = 13.2, 95% CI = 1.5–116.0] and those who consumed a high level of red meat (OR = 6.1, 95% CI = 1.1–33.2) or consistently consumed their red meat well done (OR = 5.6, 95% CI = 0.5–62.7). The association of the NAT1*10 allele with breast cancer was mainly confined to former smokers (OR = 3.3, 95% CI = 1.2–9.5). These findings are consistent with a role for the NAT1 gene in the etiology of human breast cancer.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
Aromatic and heterocyclic amines have been shown in animal studies to induce tumors of various organs (1, 2, 3) , including those of the mammary glands (2, 3, 4) . Humans are mainly exposed to these carcinogens through cigarette smoking and consumption of well-done meat (5, 6, 7, 8) . We have shown recently in a case-control study that well-done meat intake may be an important risk factor for breast cancer (9) . Similar findings have been reported elsewhere, although there are some inconsistencies among the studies (10, 11, 12, 13, 14) . The results on the association between cigarette smoking and breast cancer risk have been conflicting, with some studies reporting increased risk of breast cancer among smokers and others reporting no association or even a reduced risk (15, 16, 17, 18, 19) .

Part of the inconsistencies observed in previous studies may reflect that only a few of them have investigated potential modifying effects of relevant carcinogen-metabolizing enzymes on the associations of breast cancer with cigarette smoking and/or consumption of well-done meat (20, 21, 22, 23) . N-Acetyltransferases are believed to be important in the activation and detoxification of aromatic and heterocyclic amines (24, 25, 26) . In humans, two N-acetyltransferases (NAT1⁵ and NAT2) have been identified (26, 27, 28) . The NAT2 gene is known to be polymorphic in humans (26 , 27) . Recently, the NAT1 gene has also been shown to be polymorphic (29) . Both NAT1 and NAT2 have been shown to catalyze the metabolic activation of aromatic and heterocyclic amine carcinogens (24 , 30, 31, 32) . Several epidemiological studies, including our own study among postmenopausal Iowa women (23) , have evaluated the association between NAT2 polymorphisms and breast cancer risk, but the results from these studies have been inconclusive (20, 21, 22, 23 , 33) . In 1996, Sadrieh et al. (34) reported that NAT1 but not NAT2 activity was detectable in human mammary epithelial cells. They further showed that human mammary gland catalyzed the metabolic activation of heterocyclic amines, suggesting that NAT1 may be more important than NAT2 in the etiology of breast cancer. Prompted by this observation and findings from recent studies showing the potential etiological importance of NAT1 in other human cancers (35 , 36) , we conducted a case-control study among participants in the IWHS to investigate whether NAT1 polymorphisms associate with breast cancer risk and, further, whether the association is modified by cigarette smoking or consumption of well-done meat.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
IWHS.
Detailed descriptions of this cohort study have been published elsewhere (37, 38, 39) . Briefly, 41,836 Iowa women, ages 55–69 years, who completed a mailed questionnaire in January 1986, have been followed for mortality and cancer incidence. Virtually all IWHS participants were Caucasian women. The follow-up was accomplished through computer linkage of study participants with Iowa death certificate files, the National Death Index, and cancer diagnosis data collected by the Iowa State Health Registry, part of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. The self-administered questionnaire used in the 1986 baseline survey included information on diet and other major risk factors for cancer, such as cigarette smoking, reproductive factors, family history of cancer, prior medical conditions, and hormone use. At baseline, however, no blood sample was collected, and no information was obtained on usual intake of meat, cooking method, or usual doneness levels of meat. A case-control study with a supplementary survey to obtain information on consumption of meat and usual doneness level (see below) and DNA sample collection was conducted during 1995–1996 in a subset of cohort members.

Case-Control Study of Breast Cancer.
Eligible cases for this study included all IWHS cohort members who had breast cancer diagnosed from January 1, 1992, to December 31, 1994 (n = 453). A control sample of 900 women was randomly selected from cohort members who were alive and free of cancer on January 1, 1992. Of these 900 women, 24 were excluded from the control group because they were either later found to have a breast cancer diagnosis during the 1992–1994 period (n = 3) or were selected to participate in other IWHS ancillary projects (n = 21). The design of the study was approved by the Institutional Review Board Human Subjects Committee at the University of Minnesota and the Iowa State Health Registry. Informed consent was obtained from all women who participated in this study.

All eligible subjects were asked to complete a self-administered semiquantitative food frequency questionnaire on meat consumption during the "reference" year. Three reference years were identified (1991, 1992, and 1993), corresponding, for cases, to the years immediately prior to breast cancer diagnosis. Women in the control group of the study were also divided randomly into three groups with approximately equal sample sizes to assess their dietary habits during the same three reference years. The food questionnaire included questions on the usual consumption and preparation methods of various meats. In addition, participants reported their usual preference for level of meat doneness using a series of color photographs that represented increasing levels of doneness of hamburger (four photos), beefsteak (four photos), and bacon (three photos). Photographs were labeled by number only and represented a range of doneness levels from extremely rare to very well done. Two hundred seventy-three (60.3%) of the selected cases and 659 (75.0%) controls participated. The major reasons for nonparticipation were refusal (29.1% of cases and 18.7% of controls), inability to locate (4.9% of cases and 3.8% of controls), or death prior to contact (5.7% of cases and 2.5% of controls).

Blood samples were donated by a subset of the women who participated in this supplementary mail survey. A blood collection kit, consisting of vacutainer tubes, biological specimen packaging containers and envelopes, and instructions, was mailed to all women who agreed to donate a blood sample. Study participants were instructed to contact their physicians, have their blood drawn, and return samples via express mail using preaddressed, prepaid envelopes provided by the study. Of the 930 women who completed the survey questionnaire, 488 (156 cases and 332 controls) donated a blood sample to the study, giving a response rate of 52.5% (57.1% for cases and 49.9% for controls). Blood was drawn using vacutainers containing acid citrate dextrose solution (Becton Dickinson, Franklin Lakes, NJ). Genomic DNA was extracted from peripheral blood leukocytes according to standard methods and stored at -70°C for subsequent assays.

NAT1 genotypes were determined by a PCR RFLP-based assay (40) that differentiates among eight NAT1 alleles (NAT1*3, *4, *5, *10, *11, *14, *15, and *16) that were identified previously in human populations. Recently, three new human NAT1 alleles that encode proteins with reduced N-acetyltransferases activity have been identified: NAT1*17, *19, and *22 (41 , 42) . NAT1*17 contains a C¹⁹⁰T substitution, NAT1*19 contains a C⁹⁷T substitution, and NAT1*22 contains an A⁷⁵²T substitution. To distinguish among these new NAT1 alleles, the published NAT1 genotyping assay was modified as described below. NAT1 genotype assignments were blind to case-control status.

To detect the G^350,351C, C⁹⁷T, and/or the A⁷⁵²T nucleotide substitutions, we digested 10 µl of amplified NAT1 PCR product overnight at 37°C with BanI (10 units) and BglII (5 units) in the presence of 50 mM NaCl, 10 mM Tris-HCl (pH 7.9), 10 mM MgCl₂, and 1 mM DTT. Samples homozygous for C⁹⁷T yield bands of 398, 343, 315, and 102 bp, whereas samples homozygous for G^350,351C yield 398-, 356-, 315-, and 89-bp fragments. When both alleles contain the A⁷⁵²T substitution, the double digest yields bands at 713 and 445 bp. When neither allele contains the G^350,351C, C⁹⁷T, and A⁷⁵²T nucleotide substitutions, 445-, 398-, and 315-bp bands, respectively, result (Fig. 1) . To detect the C¹⁹⁰T nucleotide substitution, we used 0.5 µl of amplified NAT1 as the template in a 20-µl reaction containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl₂, 0.2 mM each dNTP, 210 ng of primer (169–189) 5'-GATCAAGTTGTGAGAAGAATT- 3' (boldface type indicates the nucleotide change made in the primer sequence to generate a partial EcoRI restriction site, which is underlined), 190 ng of primer (292–274) 5'-CTGGAGTGCTGTAAACATA-3', and 0.5 unit of Taq DNA polymerase. The mixture was pretreated at 94°C for 5 min, followed by 15 cycles of 30 s at 94°C, 30 s at 55°C, and 30 s at 72°C and a final 5-min extension step at 72°C. The nested PCR product was digested with the restriction enzyme EcoRI (10 units) overnight at 37°C in the presence of 50 mM NaCl, 100 mM Tris-HCl (pH 7.5), 10 mM MgCl₂, and 0.025% Triton X-100. Samples that were homozygous for the C¹⁹⁰T nucleotide substitution resulted in the loss of the EcoRI restriction site, yielding a band of 124 bp instead of 107- and 17-bp bands (Fig. 2) .

View larger version (45K): [in this window] [in a new window]   Fig. 1. Gel electrophoresis following RFLP analysis of the 1158-bp NAT1 PCR product. Lane M, molecular weight marker X174/HaeIII. The restriction digest with BanI and Bg/II indicates that the sample in Lane 4 is heterozygous for the A752T substitution. The remaining samples do not have the A752T substitution on either allele. Additionally, no samples in Lanes 1–8 have the C97T or G350,351C substitution on either allele.

View larger version (28K): [in this window] [in a new window]   Fig. 2. Gel electrophoresis following RFLP analysis of the C190T nested PCR product. Lane M , molecular weight marker X174/HaeIII; Lane C, sample homozygous for the C190T substitution used here as a positive control. EcoRI digestion results indicate that the sample in Lane 3 is heterozygous for the C190T substitution. The remaining samples do not have the C190T substitution on either allele.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Table 1 shows the case-control distribution and ORs for selected demographic variables and major risk factors identified for this cohort of women in the early years of follow-up. Information related to cigarette smoking and well-done meat intake, the main effects studied here, is also presented in Table 1 . Among women who completed the supplementary survey, the risk of breast cancer was found to be positively associated with aging, education, family history of breast cancer, estrogen use, waist:hip ratios, smoking, and well-done meat intake, although not all elevated ORs were statistically significant. With only a few exceptions, similar associations were observed among women who provided a blood sample to the study.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

 
We found in this case-control study that the NAT1*11 allele was associated with an 4-fold elevated risk of breast cancer. The risk was increased particularly among women who smoked cigarettes, consumed a high level of red meat, or had a preference for consistently well-done meat. The NAT1*10 allele was related to a slightly elevated risk of breast cancer, and this association was primarily confined to former or light smokers. These findings suggest that the NAT1 gene may play a role in the etiology of breast cancer.

Although the association between the NAT1*11 allele and breast or other human cancers has not been reported previously, the NAT1*10 allele has been linked to increased risk of bladder, colon, gastric, lung, and head and neck cancers in previous case-control studies (35 , 36 , 43, 44, 45) . Recently, Millikan et al. (33) reported no overall association of NAT1 polymorphism with breast cancer risk among African-American and white women. The risk, however, was substantially elevated among postmenopausal women with the NAT1*10 allele who had quit smoking within the past 10 years. Intriguingly, no modifying effect of the NAT1*10 allele was observed among current smokers. That study differed from ours because their NAT1 genotype method distinguishes only four alleles (NAT1*4, NAT1*3, NAT1*10, and NAT1*11) and the NAT1*11 allele was identified in only 1% of cases and 2% of controls among white women and was absent in African-American women.

In humans, two N-acetyltransferases (NAT1 and NAT2) catalyze N- and O-acetylation of various procarcinogens, notably, aromatic and heterocyclic amines (24 , 30, 31, 32) . It is believed that these procarcinogens are activated via O-acetylation and detoxified by N-acetylation (26) . The specificity of NAT1 and NAT2 in these two acetylation pathways, however, remains unclear. NAT2 is expressed primarily in the liver (46) . If this enzyme is involved in O-acetylation of aromatic and heterocyclic amines, it may be less likely that the reactive form of these compounds could reach a high level in the breast or other target organs following activation in the liver. Given the extrahepatic distribution of the NAT1 enzyme (34 , 47, 48, 49, 50) , this enzyme may be more important than the NAT2 enzyme in the activation of aromatic and heterocyclic amines in the target organs. Indeed, it has been shown that the O-acetylation of 2-amino-1-methyl-6-phenylimidazo[4,5b]pyridine and 2-amino-3-methylimidazo-(4,5-f)quinoline, two of the most abundant heterocyclic amines in well-done meat (5 , 6) , is largely carried out by NAT1 in human mammary glands (34) .

Although the link between NAT1 alleles and isozyme activity has not been directly established (46) , two studies have suggested that the NAT1*10 allele may be associated with increased NAT1 activity in the bladder and colon (47 , 48) . However, in more recent studies, individuals with the NAT1*10 allele did not reflect a more rapid phenotype in vivo (51) or in vitro in the colon (52) . The association of breast cancer with the NAT1*10 allele was weak in our study (OR = 1.3, 95% CI = 0.8–1.9), and the elevated risk was mainly confined to former (OR = 3.3, 95% CI = 1.2–9.5) or light (OR = 5.0, 95% CI = 0.4–56.2) smokers. This observation is consistent with the results from the recent study by Millikan et al. (33) . The link between the NAT1*11 allele and enzyme expression and activity remains unclear. One study reported that recombinant NAT1 11 catalyzed N-acetylation at rates 2-fold higher than NAT1 4 (53) , whereas a more recent study reported that recombinant NAT1 11 catalyzed N-acetylation at rates comparable to NAT1 4 (51) . Recently, the coding region of the NAT1*11 allele was sequenced and found to contain a G⁴⁴⁵A substitution that had not been described previously (54) . The G⁴⁴⁵A substitution in the NAT1*11 allele causes an amino acid change from valine to isoleucine. Recent studies show that this substitution resulted in a recombinant NAT1 protein that catalyzed the metabolic activation of N-hydroxy aromatic amines by O- and N,O-acetylation at rates up to 2-fold higher than wild-type recombinant human NAT1 (54) . The results of this study showing elevated risk of breast cancer with the NAT1*11 allele, particularly among women with high exposure to aromatic and heterocyclic amines, are consistent with increased activation of aromatic and heterocyclic amines in individuals carrying the NAT1*11 allele.

The primary concern of this study may be the low response rate to blood sample collection. There is no reason, however, to speculate that the response rate would be associated with both case-control status and certain genotypes. Nevertheless, we have evaluated the possibility of this selection bias by comparing women who provided blood with those who completed the supplementary questionnaire regarding well-done meat intake and found that these two groups were generally comparable in breast risk factors, including cigarette smoking and well-done meat intake. We have also shown previously that women who completed the supplementary survey were similar to all eligible women who where selected for this ancillary study in virtually all major breast cancer risk factors (9) . Therefore, this potential bias seems minimal. Passive smoking has been linked recently to an elevated risk of breast cancer in some studies (55) . Information related to passive smoking, however, was not collected in this study.

In summary, this case-control study found that postmenopausal women with the NAT1*11 allele may be at increased risk of breast cancer, particularly if they smoked cigarettes or consumed a high level of well-done meat. The NAT1*10 allele was also associated with an elevated risk among former or light smokers. These findings are consistent with the observations from recent laboratory studies, indicating the importance of the NAT1 enzyme in the in situ activation of heterocyclic amines in human breast epithelial cells, and point to the need in future studies to investigate potential interactions of genetic factors with intake of foods, food constituents, and nutrients in the etiology of cancer (56) . Our findings, particularly those related to potential gene-environment interaction, are preliminary, however, given the small sample size and relatively low frequency of the NAT1*11 allele in the study population. Therefore, in addition to laboratory studies to link the NAT1*11 allele with its enzyme function, future epidemiological studies are needed to investigate the role of the NAT1 genes in the etiology of breast cancer.

	Acknowledgments

 
We thank Drs. Lawrence Kushi, Kristin Anderson, and Myron Gross for their contributions in data and specimen collection; Dr. Rashmi Sinha for providing copies of the food photographs for assessing meat doneness level. The food frequency questionnaire used in this study was modified from the one developed by Drs. Sinha and Anderson for a case-control study of pancreatic cancer in Minnesota.

	Footnotes

 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ Supported by National Cancer Institute Grants R01 CA-39742 and R01 CA-34627 and National Action Plan on Breast Cancer, Office on Women’s Health, United States Public Health Service Supplementary Grant OWH-284.

² To whom requests for reprints should be addressed. Present address: University of South Carolina School of Public Health and South Carolina Cancer Center, 15 Richland Medical Park, # 301, Columbia, SC 29203. Phone: (803) 434-1612; Fax: (803) 434-1626; E-mail: Wei.Zheng{at}rmh.edu

³ Present address: Department of Nutrition and Food Sciences, Utah State University, Logan, UT 84321

⁴ Present address: Department of Health Science Research, Mayo Clinic Cancer Center, Rochester, MN 55905.

⁵ The abbreviations used are: NAT1 and NAT2, N-acetyltransferase 1 and 2, respectively; IWHS, Iowa Women’s Health Study; OR, odds ratio; CI, confidence interval.

Received 8/ 7/98; revised 11/30/98; accepted 1/12/99.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Ohgaki H., Takayama S., Sugimura T. Carcinogenicities of heterocyclic amines in cooked food. Mutat. Res., 259: 399-410, 1991.[Medline]
2. Nagao M., Ushijima T., Wakabayashi K., Ochiai M., Kushida H., Sugimura T., Hasegawa R., Shirai T., Ito N. Dietary carcinogens and mammary carcinogenesis. Cancer (Phila.), 74: 1063-1069, 1994.[Medline]
3. Ito N., Hasegawa R., Sano S., Tamano S., Esumi H., Takayama S., Sugimura T. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5b]pyridine (PhIP). Carcinogenesis (Lond.), 12: 1503-1506, 1991.[Abstract/Free Full Text]
4. Shirai T., Tamano S., Sano M., Masui T., Hasegawa R., Ito N. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5b]pyridine (PhIP) in rats: dose response studies Adamson R. Gustafsson J. A. Ito N. Nagao M. Sugimura T. Wakabayashi K. Yamazoe Y. eds. . Heterocyclic amines in cooked foods: possible human carcinogens., : Princeton Scientific Publication Co., Inc. Princeton, NJ 1993.
5. Adamson R. H. Mutagens and carcinogens formed during cooking of foods and methods to minimize their formation Devita V. T., Jr. Hellman S. Rosenberg S. A. eds. . Cancer Prevention, : 1-7, J. B. Lippincott Philadelphia, PA 1990.
6. Layton D. W., Bogen K. T., Knize M. G., Hatch F. T., Johnson V. M., Felton J. S. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis (Lond.), 16: 39-52, 1995.[Abstract/Free Full Text]
7. Vineis P. Epidemiology of cancer from exposure to arylamines. Environ. Health Perspect., 106 (Suppl. 6): 7-10, 1994.
8. Sinha R., Rothman N. Exposure assessment of heterocyclic amines (HCAs) in epidemiologic studies. Mutat. Res., 376: 195-202, 1997.[Medline]
9. Zheng W., Gustafson D. R., Sinha R., Cerhan J. R., Moore D., Hong C. P., Anderson K. E., Kushi L. H., Sellers T. A., Folsom A. R. Well-done meat intake and the risk of breast cancer. J. Natl. Cancer Inst. (Bethesda), 90: 1724-1729, 1998.[Abstract/Free Full Text]
10. Knekt P., Steineck G., Järvinen R., Hakulinen T., Aromaa A. Intake of fried meat and risk of cancer: a follow-up study in Finland. Int. J. Cancer, 59: 756-760, 1994.[Medline]
11. Phillips R. L. Role of life-style and dietary habits in risk of cancer among Seventh-Day Adventists. Cancer Res., 35: 3513-3522, 1975.[Medline]
12. Iscovich J. M., Iscovich R. B., Howe G., Shiboski S., Kaldor J. M. A case-control study of diet and breast cancer in Argentina. Int. J. Cancer, 44: 770-776, 1989.[Medline]
13. Matos E. L., Thomas D. B., Sobel N., Vuoto D. Breast cancer in Argentina: a case-control study with special reference to meat-eating habits. Neoplasma, 38: 357-366, 1991.[Medline]
14. De Stefani E., Ronco A., Mendilaharsu M., Guidobono M., Deneo-Pellegrini H. Meat intake, heterocyclic amines, and risk of breast cancer: a case-control study in Uruguay. Cancer Epidemiol. Biomark. Prev., 6: 573-581, 1997.[Abstract]
15. Palmer J., Rosenberg L. Cigarette smoking and breast cancer. Epidemiol. Rev., 15: 145-162, 1993.[Free Full Text]
16. Baron J., Newcomb P., Longnecker M., Mittendorf R., Storer B., Clapp R., Bogdan G., Yuen J. Cigarette smoking and breast cancer. Cancer Epidemiol. Biomark. Prev., 5: 399-405, 1996.[Abstract]
17. Morabia A., Bernstein M., Héritier S., Khatchatrian N. Relation of breast cancer with passive and active exposure to tobacco smoke. Am. J. Epidemiol., 143: 918-928, 1996.[Abstract/Free Full Text]
18. Brunet J. S., Ghadirian P., Rebbeck T. R., Lerman C., Garber J. E., Tonin P. N., Abrahamson J., Foulkes W. D., Daly M., Wagner-Costalas J., Godwin A., Olopade O. I., Moslehi R., Liede A., Futreal P. A., Weber B. L., Lenoir G. M., Lynch H. T., Narod S. A. Effects of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. J. Natl. Cancer Inst. (Bethesda), 90: 761-765, 1998.[Abstract/Free Full Text]
19. Gammon M. D., Scoenberg J. B., Teitelbaum S. L., Brinton L. A., Potischman N., Swanson C. A., Brogan D. J., Malone K. E., Stanford J. L. Cigarette smoking and breast cancer risk among young women. Am. J. Epidemiol., 147 (Suppl.): S93 1998.
20. Ambrosone C. B., Freudenheim J. L., Graham S., Marshall J., Vena J., Brasure J., Michalek A., Laughlin R., Nemoto T., Gillenwater K., Harrington A., Shields P. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms and breast cancer risk. J. Am. Med. Assoc., 276: 1494-1501, 1996.[Abstract]
21. Hunter D., Hankinson S., Hough H., Gertig D., Garcia-Closas M., Spiegelman D., Manson J., Colditz G., Willet W., Speizer F., Kelsey K. A prospective study of NAT2 acetylation genotype, cigarette smoking and risk of breast cancer. Carcinogenesis (Lond.), 18: 2127-2132, 1997.[Abstract/Free Full Text]
22. Morabia A., Bernstein M., Héritier S., Bourchardy I., Morris M. A. NAT2-smoking interaction with respect to breast cancer in menopausal women. Am. J. Epidemiol., 147 (Suppl.): S45 1998.
23. Zheng W., Gross M., Campbell D., Mink P., Cerhan J. R., Kushi L., Sellers T., Anderson K., Oetting W., Folsom A. R. Polymorphisms of the NAT2, CYP1A1, and GSTM1 genes and the risk of breast cancer. Pezcoller Found. J., 29: 1998.
24. Hein D. W., Doll M. A., Rustan T. D., Gray K., Feng Y., Ferguson R. J., Grant D. M. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis (Lond.), 14: 1633-1638, 1993.[Abstract/Free Full Text]
25. Minchin R. F., Kadlubar F. F., Ilett K. F. Role of acetylation in colorectal cancer. Mutat. Res., 290: 35-42, 1993.[Medline]
26. Hein D. W. Acetylator genotype and arylamine-induced carcinogenesis. Biochim. Biophys. Acta, 948: 37-66, 1988.[Medline]
27. Weber W. W., Hein D. W. N-Acetylation pharmacogenetics. Pharmacol. Rev., 37: 25-79, 1985.[Medline]
28. Vatsis K. P., Weber W. W., Bell D. A., Dupret J. M., Price-Evans D. A., Grant D. M., Hein D. W., Lin H. J., Meyer U. A., Relling M. V., Sim E., Suzuki T., Tamazoe Y. Nomenclature for N-acetyltransferases. Pharmacogenetics, 5: 1-17, 1995.[Medline]
29. Vatsis K. P., Weber W. W. Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus. Arch. Biochem. Biophys., 301: 71-76, 1993.[Medline]
30. Minchin R. F., Reeves P. T., Teitel C. H., McManus M. E., Mojarrabi B., Ilett K. F., Kadlubar F. F. N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. Biochem. Biophys. Res. Commun., 185: 839-844, 1992.[Medline]
31. Hein D. W., Rustan T. D., Ferguson R. J., Doll M. A., Gray K. Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases. Arch. Toxicol., 68: 129-133, 1994.[Medline]
32. Hein D. W., Doll M. A., Rustan T. D., Ferguson R. J. Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of seven specific NAT2 nucleic acid substitutions. Cancer Res., 55: 3531-3536, 1995.[Abstract/Free Full Text]
33. Millikan R. C., Pittman G. S., Newman B., Tse C-K. J., Selmin O., Rockhill B., Savitz D., Moorman P. G., Bell D. A. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol, Biomark. Prev., 7: 371-378, 1998.[Abstract]
34. Sadrieh N., Davis C. D., Snyderwine E. G. N-acetyltransferase expression and metabolic activation of food-derived heterocyclic amines in the human mammary gland. Cancer Res., 56: 2683-2687, 1996.[Abstract/Free Full Text]
35. Bell D. A., Stephens E. A., Castranio T., Umbach D. M., Watson M., Deakin M., Elder J., Jendrickse C., Duncan H., Strange R. C. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res., 55: 3537-3542, 1995.[Abstract/Free Full Text]
36. Taylor J. A., Umbach D., Stephens E., Paulson D., Robertson D., Mohler J., Bell D. A. The role of N-acetylation polymorphisms at NAT1 and NAT2 in smoking-associated bladder cancer. Proc. Am. Assoc. Cancer Res., 36: 1681 1995.
37. Kushi L. H., Sellers T. A., Potter J. D., Nelson C. L., Munger R. G., Kaye S. A., Folsom A. R. Dietary fat and postmenopausal breast cancer. J. Natl. Cancer Inst. (Bethesda), 84: 1092-1099, 1992.[Abstract/Free Full Text]
38. Folsom A. R., Kaye S. A., Sellers T. A., Hong C. P., Cerhan J. R., Potter J. D., Prineas R. J. Body fat distribution and 5-year risk of death in older women. J. Am. Med. Assoc., 269: 483-487, 1993.[Abstract]
39. Bisgard K. M., Folsom A. R., Hong C. P., Sellers T. A. Mortality and cancer rates in non-respondents to a prospective study of older women: 5-year follow-up. Am. J. Epidemiol., 139: 990-1000, 1994.[Abstract/Free Full Text]
40. Deitz A. C., Doll M. A., Hein D. W. A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles. Anal. Biochem., 253: 319-324, 1997.
41. Butcher N. J., Ilett K. F., Minchin R. F. Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations. Pharmacogenetics, 8: 67-72, 1998.[Medline]
42. Lin H. J., Probst-Hensch N. M., Hughes N. C., Sakamoto G. T., Louie A. D., Kau I. H., Lin B. K., Lee D. B., Lin J., Frankl H. D., Lee E. R., Hardy S., Grant D. M., Haile R. W. Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas. Pharmacogenetics, 8: 269-281, 1998.[Medline]
43. Abdel-Rahman S. Z., El-Zein R. A., Zwishchenberger J. B., Au W. W. Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers. Mutat. Res., 398: 43-54, 1998.[Medline]
44. Olshan A., Watson M. A., Smith J., Wiessler M., Bell D. A. Association of N-acetyltransferase 1 (NAT1) genotype and smoking with risk of head and neck cancers. Proc. Am. Assoc. Cancer Res., 8: 331 1997.
45. Katoh T., Bell D. A. The role of N-acetylation polymorphisms (NAT1 and NAT2) in gastric and colorectal adenomas. Proc. Am. Assoc. Cancer Res., 38: 619 1997.
46. Grant D. M., Hughes N., Janezic S., Goodfellow G., Chen H., Gaedigk A., Yu V., Grewal R. Human acetyltransferase polymorphisms. Mutat. Res., 376: 61-70, 1997.[Medline]
47. Bell D. A., Badawi A. F., Lang N. P., Ilett K. F., Kadlubar F. F., Hirvonen A. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res., 55: 5226-5229, 1995.[Abstract/Free Full Text]
48. Badawi A. F., Hirvonen A., Bell D. A., Lang N. P., Kadlubar F. F. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res., 55: 5230-5237, 1995.[Abstract/Free Full Text]
49. Anderson K. E., Hammons G. J., Kadlubar F. F., Potter J. D., Kaderlik K. R., Ilett K. F., Minchin R. F. Metabolic activation of aromatic amines by human pancreas. Carcinogenesis (Lond.), 18: 1085-1092, 1997.[Abstract/Free Full Text]
50. Hickman D., Pope J., Patil S. D., Fakis G., Smelt V., Stanley L. A., Payton M., Unadkat J. D., Sim E. Expression of arylamine N-acetyltransferase in human intestine. Gut, 42: 402-409, 1998.[Abstract/Free Full Text]
51. Hughes N. C., Janezic S. A., McQueen K. L., Jewett M. A. S., Castranio T., Bell D. A., Grant D. M. Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe. Pharmacogenetics, 8: 55-66, 1998.[Medline]
52. Feng, Y., Rustan, T. D., Doll, M. A., Leff, M. A., Cooley, A. M. Fretland, A. J., Gruzziotin, M. U., Luthra, E., Becker, W. K., and Hein, D. W. Human N-acetyltransferase-1 (NAT1) and -2 (NAT2) genotype/phenotype determinations in cytosolic preparations from surgical human colon specimens. In: Proceedings of the First International Workshop on the Arylamine N-Acetyltransferases, p. 23. Kuranda, Queensland, Australia: 1998.
53. de Leon J. H., Vatsis K. P., Weber W. W. Catalytic activities of human N-acetyltransferase (NAT1) variants expressed in COS-1 cells. FASEB J., 10: A456 1996.
54. Doll M. A., Jiang W., Deitz A. C., Rustan T. D., Hein D. W. Identification of a novel allele at the human NAT1 acetyltransferase locus. Biochem. Biophys. Res. Commun., 233: 584-591, 1997.[Medline]
55. Johnson K. C., Semenciw R., H J., Mao Y., and the Canadian Cancer Registries Epidemiology Research Group. Active and passive smoking and pre-menopausal breast cancer. Am. J. Epidemiol., 147 (Suppl.): S68 1998.
56. Kohlmeier L., DeMarini D., Piegorsch W. Gene-nutrient interactions in nutritional epidemiology Margetts B. M. Nelson M. eds. . Design Concepts in Nutritional Epidemiology, : 312-337, Oxford, Press Oxford, UK 1997.

This article has been cited by other articles:

				L. Jiao, M. A. Doll, D. W. Hein, M. L. Bondy, M. M. Hassan, J. E. Hixson, J. L. Abbruzzese, and D. Li Haplotype of N-Acetyltransferase 1 and 2 and Risk of Pancreatic Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2379 - 2386. [Abstract] [Full Text] [PDF]

				L. E. Mechanic, R. C. Millikan, J. Player, A. R. de Cotret, S. Winkel, K. Worley, K. Heard, K. Heard, C.-K. Tse, and T. Keku Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study Carcinogenesis, July 1, 2006; 27(7): 1377 - 1385. [Abstract] [Full Text] [PDF]

				P. D. Terry and M. Goodman Is the Association between Cigarette Smoking and Breast Cancer Modified by Genotype? A Review of Epidemiologic Studies and Meta-analysis. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 602 - 611. [Abstract] [Full Text] [PDF]

				B Thyagarajan, K E Anderson, F Kong, F R Selk, C F Lynch, and M D Gross New approaches for genotyping paraffin wax embedded breast tissue from patients with cancer: the Iowa women's health study J. Clin. Pathol., September 1, 2005; 58(9): 955 - 961. [Abstract] [Full Text] [PDF]

				I. T. Gram, T. Braaten, P. D. Terry, A. J. Sasco, H.-O. Adami, E. Lund, and E. Weiderpass Breast Cancer Risk Among Women Who Start Smoking as Teenagers Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 61 - 66. [Abstract] [Full Text] [PDF]

				P. D. Terry and T. E. Rohan Cigarette Smoking and the Risk of Breast Cancer in Women: A Review of the Literature Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 953 - 971. [Abstract] [Full Text] [PDF]

				M M de Jong, I M Nolte, G J te Meerman, W T A van der Graaf, J C Oosterwijk, J H Kleibeuker, M Schaapveld, and E G E de Vries Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility J. Med. Genet., April 1, 2002; 39(4): 225 - 242. [Abstract] [Full Text] [PDF]

				P. F. Firozi, M. L. Bondy, A. A. Sahin, P. Chang, F. Lukmanji, E. S. Singletary, M. M. Hassan, and D. Li Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer Carcinogenesis, February 1, 2002; 23(2): 301 - 306. [Abstract] [Full Text] [PDF]

				S. Garte Metabolic Susceptibility Genes As Cancer Risk Factors: Time for a Reassessment? Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1233 - 1237. [Abstract] [Full Text] [PDF]

				S. Fronhoffs, T. Bruning, E. Ortiz-Pallardo, P. Brode, B. Koch, V. Harth, A. Sachinidis, H. M. Bolt, C. Herberhold, H. Vetter, et al. Real-time PCR analysis of the N-acetyltransferase NAT1 allele *3, *4, *10, *11, *14 and *17 polymorphism in squamous cell cancer of head and neck Carcinogenesis, September 1, 2001; 22(9): 1405 - 1412. [Abstract] [Full Text] [PDF]

				D. W. Hein, C. A. McQueen, D. M. Grant, G. H. Goodfellow, F. F. Kadlubar, and W. W. Weber Pharmacogenetics of the Arylamine N-Acetyltransferases: A Symposium in Honor of Wendell W. Weber Drug Metab. Dispos., April 13, 2001; 28(12): 1425 - 1432. [Abstract] [Full Text]

				F. J. Couch, J. R. Cerhan, R. A. Vierkant, D. M. Grabrick, T. M. Therneau, V. S. Pankratz, L. C. Hartmann, J. E. Olson, C. M. Vachon, and T. A. Sellers Cigarette Smoking Increases Risk for Breast Cancer in High-Risk Breast Cancer Families Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 327 - 332. [Abstract] [Full Text]

				W. Zheng, D. Xie, J. R. Cerhan, T. A. Sellers, W. Wen, and A. R. Folsom Sulfotransferase 1A1 Polymorphism, Endogenous Estrogen Exposure, Well-done Meat Intake, and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., February 1, 2001; 10(2): 89 - 94. [Abstract] [Full Text]

				A. C. Deitz, W. Zheng, M. A. Leff, M. Gross, W.-Q. Wen, M. A. Doll, G. H. Xiao, A. R. Folsom, and D. W. Hein N-Acetyltransferase-2 Genetic Polymorphism, Well-done Meat Intake, and Breast Cancer Risk among Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., September 1, 2000; 9(9): 905 - 910. [Abstract] [Full Text]

				J. A. Williams and D. H. Phillips Mammary Expression of Xenobiotic Metabolizing Enzymes and Their Potential Role in Breast Cancer Cancer Res., September 1, 2000; 60(17): 4667 - 4677. [Abstract] [Full Text]

				A.-M. Martin and B. L. Weber Genetic and Hormonal Risk Factors in Breast Cancer J Natl Cancer Inst, July 19, 2000; 92(14): 1126 - 1135. [Abstract] [Full Text] [PDF]

				I. N. Nishimoto, T. Hanaoka, H. Sugimura, K. Nagura, M. Ihara, X.-J. Li, T. Arai, G. S. Hamada, L. P. Kowalski, and S. Tsugane Cytochrome P450 2E1 Polymorphism in Gastric Cancer in Brazil: Case-Control Studies of Japanese Brazilians and Non-Japanese Brazilians Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 675 - 680. [Abstract] [Full Text]

				J.A. Williams, E. M. Stone, B. C. Millar, A. Hewer, and D. H. Phillips Pathways of heterocyclic amine activation in the breast: DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) formed by peroxidases and in human mammary epithelial cells and fibroblasts Mutagenesis, March 1, 2000; 15(2): 149 - 154. [Abstract] [Full Text] [PDF]

				S. THOMPSON Abreast of the West: German effort to distract Poles from the truth about smoking Tob. Control, March 1, 2000; 9(1): 102 - 103. [Full Text] [PDF]